Clinical Trial

Pharmacokinetics of Neostigmine and Glycopyrrolate

Study Description

Pharmacokinetics of Neostigmine and Glycopyrrolate

A group of 6 able-bodied healthy volunteers will receive Neostigmine (NEO) and Glycopyrrolate (GLY) intravenously and via 3 different methods of Iontophoresis (ION) with subsequent blood draws over 1 hour in order to measure the pharmacokinetic behavior of the drugs en-vivo.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Combination of Neostigmine and Glycopyrrolate

Intravenous or transdermal

Device - I-Box by Dynatronics

Electric field conducting drugs through the skin without compromising its integrity

Additional Information

Official Study Title

Pharmacokinetics of Neostigmine and Glycopyrrolate After Intravenous and Transcutaneous Administration by Iontophoresis

Clinical Trial ID

NCT04027972

ParticipAid ID

eZ6xwe